Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2009
12/08/2009CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009CA2375986C Substituted pyrazole compounds
12/08/2009CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/08/2009CA2315113C Pyridones as src family sh2 domain inhibitors
12/03/2009WO2009145899A1 5-substituted isoindoline compounds
12/03/2009WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009WO2009145852A1 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof
12/03/2009WO2009145720A1 Isoindoline derivatives comprising additional heterocyclic groups and their use in the treatment of pain disorders
12/03/2009WO2009145718A1 Isoindoline derivatives comprising an additional heterocyclic group and their use in the treatment of pain disorders
12/03/2009WO2009145368A1 Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
12/03/2009WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009WO2009145357A1 In 1-position durch einen ring substituierte benzo [1, 4] diazepine zur verwendungs als antidepressiva
12/03/2009WO2009144961A1 Substituted carbinol compound having cyclic linker
12/03/2009WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009WO2009126672A3 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
12/03/2009WO2009125923A3 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
12/03/2009WO2009124906A3 A polymorph of argatroban monohydrate and a process for its synthesis
12/03/2009WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/03/2009WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009WO2009095872A3 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
12/03/2009WO2008026219A3 Novel polymorphs of rimonabant
12/03/2009US20090299071 Triazole derivative or salt thereof
12/03/2009US20090299066 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/03/2009US20090299064 Methods and intermediates for the preparation of optionally radio-labeled imatinib
12/03/2009US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
12/03/2009US20090298885 Methylene urea derivatives
12/03/2009US20090298884 Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same
12/03/2009US20090298882 Thioxoisoindoline compounds and compositions comprising and methods of using the same
12/03/2009US20090298878 Oxime compounds and the use thereof
12/03/2009US20090298872 Compounds and compositions as modulators of steroidal receptors and calcium channel activities
12/03/2009US20090298855 Protein Tyrosine Kinase Inhibitors
12/03/2009US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
12/03/2009US20090298846 such as 6-[2-(4-Hydroxyphenyl)ethylamino]-11H-indolo[3,2-c]quinoline, used to inhibit both growth of cancer cells and activity of telomerase
12/03/2009US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity
12/03/2009US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators
12/03/2009US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity
12/03/2009US20090298829 Melanocortin receptor agonists
12/03/2009US20090298826 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
12/03/2009US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
12/03/2009US20090298816 Pesticides containing a bicyclic bisamide structure
12/03/2009US20090298812 Substituted Sulfonamide Compounds
12/03/2009US20090297594 Oral Pharmaceutical Dosage Forms Comprising a Proton Pump Inhibitor and a NSAID
12/03/2009US20090297445 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled amides using metal amides and phot-induced free radical carbonylation
12/03/2009US20090297443 Labeled ALPHA4BETA2 Ligands and Methods Therefor
12/03/2009CA2725603A1 5-substituted isoindoline compounds
12/03/2009CA2725111A1 Substituted carbinol compound having a cyclic linker
12/03/2009CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/02/2009EP2128155A1 Triazole derivative or salt thereof
12/02/2009EP2128154A1 Benzimidazole compound and pharmaceutical use thereof
12/02/2009EP2128138A1 Pyrazole compound
12/02/2009EP2128136A1 2-phenylnicotinic acid derivative
12/02/2009EP2125787A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof
12/02/2009EP2125785A1 Indoles
12/02/2009EP2125783A2 Process for the preparation of esomeprazole magnesium dihydrate
12/02/2009EP2125779A1 Polymorphs of a mglur5 receptor antagonist
12/02/2009EP2125776A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP2125745A1 Cycloalkylamine substituted isoquinolone derivatives
12/02/2009EP2125744A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
12/02/2009EP2125733A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
12/02/2009EP2125727A1 Stable s-nitrosothiols, method of synthesis and use
12/02/2009EP2125720A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor
12/02/2009EP2125718A2 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
12/02/2009EP2124565A2 N-substituted glycine derivatives: hydroxylase inhibitors
12/02/2009EP2124562A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/02/2009EP1902046B1 Piperidine derivatives useful as histamine h3 antagonists
12/02/2009EP1896453B1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
12/02/2009EP1861360B1 Pyrrolidine derivatives as histamine h3 receptor antagonists
12/02/2009EP1856093B1 (2R,4aR,10bR)-6-(2,6-dimethoxypyridin-3-yl)-9-ethoxy-8-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol, HCl salt
12/02/2009EP1664029B1 Quinazoline derivatives as antitumor agents
12/02/2009EP1606289B1 Carboxamide derivatives
12/02/2009EP1606284B1 Compositions useful as protein kinase inhibitors
12/02/2009EP1583742B1 Cb 1 receptour inverse agonists
12/02/2009EP1551827B1 Piperidine derivatives as ccr5 inhibitors
12/02/2009EP1542684B1 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
12/02/2009EP1537097B1 Method for preparing 3-halo-4,5-dihydro-1 i h /i -pyrazoles
12/02/2009EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009EP1389203B1 Analogs of thalidomide as angiogenesis inhibitors
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009CN101595107A Substituted piperidines that increase P53 activity and the uses thereof
12/02/2009CN101595102A Biaryl ether urea compounds
12/02/2009CN101595101A Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/02/2009CN101595100A Heterocyclic-substituted piperidine as ORL-1 ligands
12/02/2009CN101595094A Cycloalkylamine substituted isoquinolone derivatives
12/02/2009CN101595093A Organic compounds
12/02/2009CN101595084A Biaryl compositions and methods for modulating a kinase cascade
12/02/2009CN101591354A Functionalized ionic liquids, and methods of use thereof
12/02/2009CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
12/02/2009CN101591331A Method for preparing hindered amine light stabilizer
12/02/2009CN101591330A Sertindole crystal form and preparation method thereof
12/02/2009CN101591329A Method for preparing chiral azelnidipine and acceptable salt thereof
12/02/2009CN101591295A Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof
12/02/2009CN100564394C Pefloxacin couple and its preparing method and use
12/02/2009CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine
12/02/2009CN100564344C 2- and 2,5-substituted phenylketo-enols